Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 10, 2009 - Issue 1
Submit an article Journal homepage
222
Views
6
CrossRef citations to date
0
Altmetric
Reviews

Pharmacotherapy of idiopathic generalized epilepsies

Paolo Curatolo Tor Vergata University, Pediatric Neurology Unit, Department of Neurosciences, Rome, 00133, Italy +39 06 20900249; +39 06 20900018; [email protected]
,
Romina Moavero Tor Vergata University, Pediatric Neurology Unit, Department of Neurosciences, Rome, 00133, Italy +39 06 20900249; +39 06 20900018; [email protected]
,
Adriana Lo Castro Tor Vergata University, Pediatric Neurology Unit, Department of Neurosciences, Rome, 00133, Italy +39 06 20900249; +39 06 20900018; [email protected]
&
Caterina Cerminara Tor Vergata University, Pediatric Neurology Unit, Department of Neurosciences, Rome, 00133, Italy +39 06 20900249; +39 06 20900018; [email protected]
Pages 5-17 | Published online: 16 Dec 2008

Bibliography

  • Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-99
  • Engel J Jr. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on classification and terminology. Epilepsia 2001;42:796-803
  • Engel J Jr. Report of the ILAE classification core group. Epilepsia 2006;47:1558-68
  • Jallon P, Latour P. Epidemiology of idiopathic generalized epilepsies. Epilepsia 2005;46(Suppl 9):10-14
  • Koutroumanidis M, Bourvari G, Tan SV. Idiopathic generalized epilepsies: clinical and electroencephalogram diagnosis and treatment. Expert Rev Neurother 2005;5:753-67
  • Martinez-Juarez IE, Alonso ME, Medina MT, et al. Juvenile myoclonic epilepsy subsyndromes: family studies and long-term follow-up. Brain 2006;129:1269-80
  • Caplan R, Siddarth P, Stahl L, et al. Childhood absence epilepsy: behavioral, cognitive, and linguistic comorbidities. Epilepsia 2008
  • Italian League Against Epilepsy Genetic Collaborative Group. Concordance of clinical forms of epilepsy in families with several affected members. Epilepsia 1993;34:819-26
  • Berkovic SF, Howell RA, Hay DA, Hopper JL. Epilepsies in twins: genetics of the major epilepsy syndromes. Ann Neurol 1998;43:435-45
  • Glasscock E, Qian J, Yoo JW, Noebels JL. Masking epilepsy by combining two epilepsy genes. Nat Neurosci 2007;10(12):1554-8
  • Berkovic SF, Scheffer IE. Genetics of the epilepsies. Epilepsia 2001;42(Suppl 5):16-23
  • Guerrini R. Epilepsy in children. Lancet 2006;367(9509):499-524
  • Semah F, Picot MC, Adam C, et al. Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology 1998;51(5):1256-62
  • Holmes GL. Models for generalized seizures. Suppl Clin Neurophysiol 2004;57:415-24
  • Holmes GL, Zhao Q. Choosing the correct antiepileptic drugs: from animal studies to the clinic. Pediatr Neurol 2008;38(3):151-62
  • Crunelli V, Leresche N. Childhood absence epilepsy: genes, channels, neurons and networks. Nat Rev Neurosci 2002;3(5):371-82
  • Oller L. Prospective study of the differences between the syndromes of infantile absence epilepsy and syndromes of juvenile absence epilepsy. Rev Neurol 1996;24(132):930-6
  • Hirose S, Okada M, Yamakawa K, et al. Genetic abnormalities underlying familial epilepsy syndromes. Brain Dev 2002;24(4):211-22
  • Mulley JC, Scheffer IE, Petrou S, Berkovic SF. Channelopathies as a genetic cause of epilepsy. Curr Opin Neurol 2003;16:171-6
  • Everett KV, Chioza B, Aicardi J, et al. Linkage and association analysis of CACNG3 in childhood absence epilepsy. Eur J Hum Genet 2007;15(4):463-72
  • Everett K, Chioza B, Aicardi J, et al. Linkage and mutational analysis of CLCN2 in childhood absence epilepsy. Epilepsy Res 2007;75(2-3):145-53
  • Callenbach PM, van den Maagdenberg AM, Frants RR, Brouwer OF. Clinical and genetic aspects of idiopathic epilepsies in childhood. Eur J Paediatr Neurol 2005;9(2):91-103
  • Gardiner M. Genetics of idiopathic generalized epilepsies. Epilepsia 2005;46(Suppl 9):15-20
  • Gutierrez-Delicado E, Serratosa JM. Genetics of the epilepsies. Curr Opin Neurol 2004;17(2):147-53
  • Lerche H, Weber YG, Jurkat-Rott K, Lehmann-Horn F. Ion channel defects in idiopathic epilepsies. Curr Pharm Des 2005;11(21):2737-52
  • Obeid T. Clinical and genetic aspects of juvenile absence epilepsy. J Neurol 1994;241(8):487-91
  • Wolf P, Goosses R. Relation of photosensitivity to epileptic syndromes. J Neurol Neurosurg Psychiatry 1986;49(12):1386-91
  • Zara F, Bianchi A, Avanzini G, et al. Mapping of genes predisposing to idiopathic generalized epilepsy. Hum Mol Genet 1995;4(7):1201-7
  • Aliberti V, Grunewald RA, Panayiotopoulos CP, Chroni E. Focal electroencephalographic abnormalities in juvenile myoclonic epilepsy. Epilepsia 1994;35:297-301
  • Lancman ME, Asconape JJ, Penry JK. Clinical and EEG asymmetries in juvenile myoclonic epilepsy. Epilepsia 1994;35:302-6
  • Lucarini N, Verrotti A, Napolioni V, et al. Genetic polymorphisms and idiopathic generalized epilepsies. Pediatr Neurol 2007;37:157-64
  • Kaminska A, Ickowicz A, Plouin P, et al. Delineation of cryptogenic Lennox-Gastaut syndrome and myoclonic astatic epilepsy using multiple correspondence analysis. Epilepsy Res 1999;36:15-29
  • Meisler MH, Kearney J, Ottman R, Escayg A. Identification of epilepsy genes in human and mouse. Annu Rev Genet 2001;35:567-88
  • Baulac S, Huberfeld G, Gourfinkel-An I, et al. First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene. Nat Genet 2001;28:46-8
  • Escayg A, MacDonald BT, Meisler MH, et al. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet 2000;24(4):343-5
  • Wallace RH, Wang DW, Singh R, et al. Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta1 subunit gene SCN1B. Nat Genet 1998;19(4):366-70
  • Wallace RH, Marini C, Petrou S, et al. Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet 2001;28:49-52
  • Marini C, Mei D, Temudo T, et al. Idiopathic epilepsies with seizures precipitated by fever and SCN1A abnormalities. Epilepsia 2007;48:1678-85
  • Wallace RH, Scheffer IE, Barnett S, et al. Neuronal sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures plus. Am J Hum Genet 2001;68:859-65
  • Mulley JC, Scheffer IE, Petrou S, et al. SCN1A mutations and epilepsy. Hum Mutat 2005;25:535-42
  • Harkin LA, Bowser DN, Dibbens LM, et al. Truncation of the GABA(A)-receptor gamma2 subunit in a family with generalized epilepsy with febrile seizures plus. Am J Hum Genet 2002;70:530-6
  • Guerrini R, Genton P. Epileptic syndromes and visually induced seizures. Epilepsia 2004;45(Suppl 1):14-18
  • Porciatti V, Bonanni P, Fiorentini A, Guerrini R. Lack of cortical contrast gain control in human photosensitive epilepsy. Nat Neurosci 2000;3:259-63
  • Joshi CN, Patrick J. Eyelid myoclonia with absences: routine EEG is sufficient to make a diagnosis. Seizure 2007;16:254-60
  • Genton P, Ferlazzo E, Thomas P. Absence status epilepsy: delineation of a distinct idiopathic generalized epilepsy syndrome. Epilepsia 2008;49:642-9
  • Panayiotopoulos CP. Syndromes of idiopathic generalized epilepsies not recognized by the International League Against Epilepsy. Epilepsia 2005;46(Suppl 9):57-66
  • Panayiotopoulos CP, Ferrie CD, Koutroumanidis M, et al. Idiopathic generalised epilepsy with phantom absences and absence status in a child. Epileptic Disord 2001;3(2):63-66
  • Biraben A, Allain H, Scarabin JM, et al. Exacerbation of juvenile myoclonic epilepsy with lamotrigine. Neurology 2000;55(11):1758
  • Crespel A, Genton P, Berramdane M, et al. Lamotrigine associated with exacerbation or de novo myoclonus in idiopathic generalized epilepsies. Neurology 2005;65(5):762-4
  • Thomas P, Valton L, Genton P. Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy. Brain 2006;129:1281-92
  • Gelisse P, Genton P, Kuate C, et al. Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies. Epilepsia 2004;45:1282-6
  • Gayatri NA, Livingston JH. Aggravation of epilepsy by anti-epileptic drugs. Dev Med Child Neurol 2006;48:394-8
  • Chaves J, Sander JW. Seizure aggravation in idiopathic generalized epilepsies. Epilepsia 2005;46(Suppl 9):133-9
  • Panayiotopoulos CP. Treatment of typical absence seizures and related epileptic syndromes. Paediatr Drugs 2001;3:379-403
  • Obeid T, Panayiotopoulos CP. Clonazepam in juvenile myoclonic epilepsy. Epilepsia 1989;30:603-6
  • Legros B, Boon P, Dejonghe P, et al. Opinion of Belgian neurologists on antiepileptic drugs: Belgian Study on Epilepsy Treatment (BESET). Acta Neurol Scand 2007;115:97-103
  • Grunewald R. Levetiracetam in the treatment of idiopathic generalized epilepsies. Epilepsia 2005;46(Suppl 9):154-60
  • Valencia I, Pinol-Ripoll G, Khurana DS, et al. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy. Eur J Paediatr Neurol 2008
  • Covanis A, Stodieck SR, Wilkins AJ. Treatment of photosensitivity. Epilepsia 2004;45(Suppl 1):40-5
  • Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 2007;369(9566):1016-26
  • Marson AG, Appleton R, Baker GA, et al. A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial. Health Technol Assess 2007;11(37):iii-iv, ix-x, 1-134
  • Verrotti A, Cerminara C, Coppola G, et al. Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents. Dev Med Child Neurol 2008;50:29-32
  • Shorvon SD, Lowenthal A, Janz D, et al. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group. Epilepsia 2000;41:1179-86
  • Koukkari MW, Guarino EJ. Retrospective study of the use of levetiracetam in childhood seizure disorders. J Child Neurol 2004;19:944-7
  • Verrotti A, Cerminara C, Domizio S, et al. Levetiracetam in absence epilepsy: long term efficacy in newly diagnosed patients. Dev Med Child Neurol 2008;50:850-3
  • Krauss GL, Betts T, Abou-Khalil B, et al. Levetiracetam treatment of idiopathic generalised epilepsy. Seizure 2003;12:617-20
  • Verrotti A, Cerminara C, Domizio S, et al. Levetiracetam in absence epilepsy: long term efficacy in newly diagnosed patients. Dev Med Child Neurol In press
  • Sharpe DV, Patel AD, Abou-Khalil B, Fenichel GM. Levetiracetam monotherapy in juvenile myoclonic epilepsy. Seizure 2008;17:64-8
  • Striano P, Sofia V, Capovilla G, et al. A pilot trial of levetiracetam in eyelid myoclonia with absences (Jeavons syndrome). Epilepsia 2008;49:425-30
  • Kothare SV, Kaleyias J, Mostofi N, et al. Efficacy and safety of zonisamide monotherapy in a cohort of children with epilepsy. Pediatr Neurol 2006;34:351-4
  • Iinuma K, Haginoya K. Clinical efficacy of zonisamide in childhood epilepsy after long-term treatment: a postmarketing, multi-institutional survey. Seizure 2004;13(Suppl 1):S34-9; discussion S40
  • Sato S, White BG, Penry JK, et al. Valproic acid versus ethosuximide in the treatment of absence seizures. Neurology 1982;32:157-63
  • Schmitt B, Kovacevic-Preradovic T, Critelli H, Molinari L. Is ethosuximide a risk factor for generalised tonic-clonic seizures in absence epilepsy? Neuropediatrics 2007;38(2):83-7
  • Faught E. Clinical trials for treatment of primary generalized epilepsies. Epilepsia 2003;44(Suppl 7):44-50
  • Frank LM, Enlow T, Holmes GL, et al. Lamictal (lamotrigine) monotherapy for typical absence seizures in children. Epilepsia 1999;40:973-9
  • Buchanan N. The use of lamotrigine in juvenile myoclonic epilepsy. Seizure 1996;5:149-51
  • Ferrie CD, Robinson RO, Knott C, Panayiotopoulos CP. Lamotrigine as an add-on drug in typical absence seizures. Acta Neurol Scand 1995;91:200-2
  • Rowan AJ, Meijer JW, de Beer-Pawlikowski N, et al. Valproate-ethosuximide combination therapy for refractory absence seizures. Arch Neurol 1983;40(13):797-802
  • Mattson RH, Cramer JA. Valproic acid and ethosuximide interaction. Ann Neurol 1980;7:583-4
  • Landmark CJ, Rytter E, Johannessen SI. Clinical use of antiepileptic drugs at a referral centre for epilepsy. Seizure 2007;16:356-64
  • Noachtar S, Andermann E, Meyvisch P, et al. Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures. Neurology 2008;70(8):607-16
  • Faught E. Treatment of refractory primary generalized epilepsy. Rev Neurol Dis 2004;1(Suppl 1):S34-43
  • Jenssen S, Sperling MR, Tracy JI, et al. Corpus callosotomy in refractory idiopathic generalized epilepsy. Seizure 2006;15:621-29
  • Kostov H, Larsson PG, Roste GK. Is vagus nerve stimulation a treatment option for patients with drug-resistant idiopathic generalized epilepsy? Acta Neurol Scand Suppl 2007;187:55-8
  • Nei M, O'Connor M, Liporace J, Sperling MR. Refractory generalized seizures: response to corpus callosotomy and vagal nerve stimulation. Epilepsia 2006;47:115-22
  • D'Agostino MD, Andermann F, Dubeau F, et al. Exceptionally long absence status: multifactorial etiology, drug interactions and complications. Epileptic Disord 1999;1:229-32
  • Gastaut H, Bernard R, Naquet R, Wilson J. Daily clinical and electrical study of a simple epileptic confusional state of a month's duration. Rev Neurol (Paris ) 1956;94(3):267-72
  • Shorvon S, Walker M. Status epilepticus in idiopathic generalized epilepsy. Epilepsia 2005;46(Suppl 9):73-9
  • Knake S, Gruener J, Hattemer K, et al. Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus. J Neurol Neurosurg Psychiatry 2008;79(5):588-9
  • Artama M, Auvinen A, Raudaskoski T, et al. Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology 2005;64(11):1874-8
  • Morrow J, Russell A, Guthrie E, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK epilepsy and pregnancy register. J Neurol Neurosurg Psychiatry 2006;77(2):193-8
  • Haug K, Warnstedt M, Alekov AK, et al. Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies. Nat Genet 2003;33:527-32
  • Cossette P, Liu L, Brisebois K, et al. Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nat Genet 2002;31(2):184-9
  • Kananura C, Haug K, Sander T, et al. A splice-site mutation in GABRG2 associated with childhood absence epilepsy and febrile convulsions. Arch Neurol 2002;59(7):1137-41
  • McCormick DA, Contreras D. On the cellular and network bases of epileptic seizures. Annu Rev Physiol 2001;63:815-46
  • Lukyanetz EA, Shkryl VM, Kostyuk PG. Selective blockade of N-type calcium channels by levetiracetam. Epilepsia 2002;43:9-18
  • Niespodziany I, Klitgaard H, Margineanu DG. Levetiracetam inhibits the high-voltage-activated Ca(2+) current in pyramidal neurones of rat hippocampal slices. Neurosci Lett 2001;306(1-2):5-8
  • Lynch BA, Lambeng N, Nocka K, et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 2004;101(26):9861-6
  • Crowder KM, Gunther JM, Jones TA, et al. Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A). Proc Natl Acad Sci USA 1999;96(26):15268-73
  • Xu T, Bajjalieh SM. SV2 modulates the size of the readily releasable pool of secretory vesicles. Nat Cell Biol 2001;3:691-8
  • Kaminski RM, Matagne A, Leclercq K, et al. SV2A protein is a broad-spectrum anticonvulsant target: functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy. Neuropharmacology 2008;54(4):715-20
  • Carunchio I, Pieri M, Ciotti MT, et al. Modulation of AMPA receptors in cultured cortical neurons induced by the antiepileptic drug levetiracetam. Epilepsia 2007;48:654-62
  • Cuadrado A, de Las Cuevas I, Valdizan EM, Armijo JA. Synergistic interaction between valproate and lamotrigine against seizures induced by 4-aminopyridine and pentylenetetrazole in mice. Eur J Pharmacol 2002;453(1):43-52
  • Remy S, Beck H. Molecular and cellular mechanisms of pharmacoresistance in epilepsy. Brain 2006;129:18-35
  • Szoeke CE, Newton M, Wood JM, et al. Update on pharmacogenetics in epilepsy: a brief review. Lancet Neurol 2006;5(2):189-96

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.